Summit Trail Advisors’s OptiNose OPTN Stock Holding History

Summit Trail Advisors’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-259	Closed	-$109K	–	398
2018 Q2	$109K	Buy	+259	New	+$87.3K	0.04%	199

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Summit Trail Advisors's OPTN Position: Q3 2018 in Review

Summit Trail Advisors sold out of OptiNose (OPTN) in Q3 2018, closing a stake of 259 shares — an estimated $109K sold.

Summit Trail Advisors first reported a position in OPTN in Q2 2018 and held it in 1 quarter. The position peaked at $109K in Q2 2018. 64 funds tracked by Wall St. Rank hold OPTN as of Q3 2018.

Summit Trail Advisors reported no remaining OptiNose position as of Q3 2018 after selling out during the quarter.
Summit Trail Advisors sold 259 OptiNose shares in Q3 2018, an estimated $109K.
Summit Trail Advisors first reported a position in OptiNose in Q2 2018 and held it in 1 quarter.
Summit Trail Advisors's OptiNose position peaked at $109K in Q2 2018.
64 funds tracked by Wall St. Rank held OptiNose as of Q3 2018.

Based on Summit Trail Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.